Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Anticancer Res ; 29(1): 379-83, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19331176

ABSTRACT

We have previously reported that tropolone (T-3), 2,4-dibromo-7-methoxytropone (T-21), diethyl 2-chloroazulene-1,3-dicarboxylate (A-9), 1,3-difluoroazulene (A-11), 3-morpholino-1,5-azulenequinone (AQ-8) and 3,7-dibromo-1,5-azulenequinone (AQ-13) inhibited the nitric oxide (NO) production of lipopolysaccharide (LPS)-activated mouse macrophage-like RAW264.7 cells, with or without the inhibition of inducible NO synthase (iNOS) mRNA and protein expression. In order to confirm the anti-inflammatory potency, possible effects on prostaglandin (PG) E2 production and the expression of enzymes involved in the arachidonic acid pathway were investigated. Among these six compounds, only A-9 effectively inhibited the PGE2 production of the LPS-stimulated RAW264.7 cells. Western blot analysis demonstrated that A-9 inhibited phospholipase A2 (PLA2), cyclooxygenase (COX)-2 and iNOS proteins only by 12, 45 and 42%, respectively. These data demonstrate the lack of correlation between the extent of inhibition of iNOS protein expression by tropolone or azulene derivatives and that of PGE2, and suggest the possible antiinflammatory potency of A-9.


Subject(s)
Azulenes/pharmacology , Dinoprostone/biosynthesis , Macrophages, Peritoneal/drug effects , Macrophages, Peritoneal/metabolism , Quinones/pharmacology , Tropolone/analogs & derivatives , Animals , Cyclooxygenase 2 Inhibitors/pharmacology , Lipopolysaccharides/pharmacology , Macrophage Activation , Macrophages, Peritoneal/enzymology , Mice , Mice, Inbred BALB C , Nitric Oxide Synthase Type II/antagonists & inhibitors , Phospholipase A2 Inhibitors , Tropolone/pharmacology
2.
Anticancer Res ; 28(1A): 171-8, 2008.
Article in English | MEDLINE | ID: mdl-18383842

ABSTRACT

The effect of 20 trihaloacetylazulene derivatives with one halogen atom, on nitric oxide (NO) production by mouse macrophage-like cells Raw 264.7 was investigated. 2-Methoxyazulenes and 2-ethoxyazulenes exhibited comparable cytotoxicity. Trichloroacetylazulenes generally exhibited higher cytotoxicity, as compared with the corresponding trifluoroacetylazulenes. Substitution of chloride, bromide or iodine at the C-3 position further enhanced their cytotoxicity. All of these compounds failed to stimulate the Raw 264.7 cells to produce detectable amounts of NO, but did inhibit NO production by LPS-activated Raw 264.7 cells to different extents. 1-Trichloroacetyl-2-methoxyazulene and 1-trichloroacetyl-2-ethoxyazulene, with less cytotoxic activity, inhibited NO production to the greatest extent, producing the highest selectivity index (SI) of >24.7 and >28.7, respectively. This was accompanied by the efficient inhibition of inducible NO synthase (iNOS) mRNA expression, but not by iNOS protein abundance. Electron spin resonance (ESR) spectroscopy showed that neither of these compounds produced radicals, nor scavenged NO, superoxide anion or diphenyl-2-picrylhydrazyl radicals. The present study suggests that the inhibitory effects of trifluoroacetylazulenes and trichloroacetylazulenes on NO production by activated macrophages might be derived from the perturbation of NO anabolism (inhibition of iNOS mRNA expression and possibly the inactivation of iNOS protein) rather than NO catabolism (NO scavenging).


Subject(s)
Azulenes/pharmacology , Macrophages/drug effects , Nitric Oxide/antagonists & inhibitors , Acetylation , Animals , Electron Spin Resonance Spectroscopy , Free Radical Scavengers/pharmacology , Hydrocarbons, Halogenated/pharmacology , Lipopolysaccharides/pharmacology , Macrophages/enzymology , Macrophages/metabolism , Mice , Nitric Oxide/biosynthesis , Nitric Oxide Synthase Type II/biosynthesis , Nitric Oxide Synthase Type II/genetics , Nitric Oxide Synthase Type II/metabolism , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Structure-Activity Relationship
3.
Anticancer Res ; 27(1A): 133-43, 2007.
Article in English | MEDLINE | ID: mdl-17352225

ABSTRACT

Twenty trihaloacetylazulene derivatives with one atom of fluorine, chlorine, bromine or iodine was investigated for their tumor-specific cytotoxicity and apoptosis-inducing activity against three human normal cells (gingival fibroblast, HGF; pulp cell, HPC; periodontal ligament fibroblast, HPLF) and four human tumor cell lines (squamous cell carcinoma, HSC-2, HSC-3, HSC-4; promyelocytic leukemia, HL-60). There was no apparent difference in the cytotoxic activity between 2-methoxyazulenes [1a-1e, 2a-2e] and 2-ethoxyazulenes [3a-3e, 4a-4e]. Trichloroacetylazulenes [2a-2e, 4a-4e] generally showed higher cytotoxicity and tumor-specificity (expressed as a TS value) as compared with the corresponding trifluoroacetylazulenes [1a-1e, 3a-3e]. Substitution of chloride [1c, 2c, 3c. 4c], bromide [1d, 2d, 3d, 4d] or iodine [1e, 2e, 3e, 4e] at the C-3 position further enhanced cytotoxic activity against four tumor cell lines, especially HL-60 cells. Among twenty trihaloacetylazulene derivatives, two compounds [2d] and [4c] showed the highest tumor specificity (TS = > 3.5 and > 2.5, respectively). Compounds [2d] and [4c] induced apoptotic cell death characterized by caspase-3, -8 and -9 activation and internucleosomal DNA fragmentation in HL-60 cells. On the other hand, compounds [2d] and [4c] induced autophagic cell death characterized by lower activation of caspases, lack of DNA fragmentation, vacuolization and autophagosome formation detected by acridine orange and LC3-GFP fluorescence, without the decline of the intracellular concentration of three major polyamines in HSC-4 cells. The cytotoxic activity of [4c], but not [2d], was slightly reduced by 3-methyladenine, an inhibitor of autophagy. These results suggest the diversity of cell death type induced in human tumor cell lines by trihaloacetylazulene derivatives.


Subject(s)
Apoptosis/drug effects , Autophagy/drug effects , Azulenes/pharmacology , Carcinoma, Squamous Cell/drug therapy , Hydrocarbons, Halogenated/pharmacology , Mouth Neoplasms/drug therapy , Apoptosis/physiology , Autophagy/physiology , Azulenes/chemistry , Carcinoma, Squamous Cell/pathology , Cell Line , Cell Line, Tumor , Drug Screening Assays, Antitumor , Fibroblasts/cytology , Fibroblasts/drug effects , HL-60 Cells , Humans , Hydrocarbons, Halogenated/chemistry , Mouth Neoplasms/pathology , Structure-Activity Relationship
4.
Anticancer Res ; 26(4B): 2921-7, 2006.
Article in English | MEDLINE | ID: mdl-16886614

ABSTRACT

The effects of 26 trihaloacetylazulene derivatives on nitric oxide (NO) production by the mouse macrophage-like Raw 264.7 cells was investigated. The trichloroacetylazulenes [1b-13b] generally showed higher cytotoxicity as compared with the corresponding trifluoroacetylazulenes [1a-13a]. All the compounds inhibited NO production by lipopolysaccharide (LPS)-activated Raw 264.7 cells to various extents. 3-Trifluoroacetylguaiazulene [8a], 1-trifluoroacetyl-4,6,8-trimethylazulene [10a], 3-methyl-l-trichloroacetylazulene [2b] and 3-ethyl-1-trichloroacetylazulene [3b] showed lower cytotoxic activity and most effectively inhibited NO production. Western blot analysis revealed that compounds [8a, 1Oal dose-dependently reduced the intracellular concentration of inducible NO synthase (iNOS), whereas compounds [2b, 3b] only marginally affected the iNOS protein expression. RT-PCR analysis showed that compounds [8a, 2b] reduced the iNOS mRNA expression by approximately 50%. These compounds affected cyclooxygenase-2 protein and mRNA expression, depending on the concentrations. ESR spectroscopy revealed that compounds [8a, 10a, 2b, 3b] neither produced radical, nor scavenged NO, superoxide anion or diphenyl-2-picrylhydrazyl radicals. The present study showed the inhibitory effects of trifluoroacetylazulenes and trichloroacetylazulenes on NO production by activated macrophages.


Subject(s)
Azulenes/pharmacology , Lipopolysaccharides/pharmacology , Macrophages/drug effects , Macrophages/metabolism , Nitric Oxide/antagonists & inhibitors , Animals , Azulenes/chemistry , Blotting, Western , Cell Line , Cyclooxygenase 2/biosynthesis , Dinoprostone/biosynthesis , Electron Spin Resonance Spectroscopy , Free Radical Scavengers/pharmacology , Macrophages/enzymology , Mice , Nitric Oxide/biosynthesis , Nitric Oxide Synthase Type II/biosynthesis , Structure-Activity Relationship
5.
Anticancer Res ; 26(3A): 1917-23, 2006.
Article in English | MEDLINE | ID: mdl-16827125

ABSTRACT

Twenty-six trihaloacetylazulene derivatives were investigated for their tumor-specific cytotoxicity and apoptosis-inducing activity against three human normal cells (HGF, HPC, HPLF) and four human tumor cell lines (HSC-2, HSC-3, HSC-4, HL-60). The trichloroacetylazulenes [1b-13b] generally showed higher cytotoxicity as compared to the corresponding trifluoroacetylazulenes [1a-13a]. The trichloroacetylazulenes [1b-13b] also showed higher tumor-specific cytotoxicity (expressed as TS value) than the corresponding trifluoroacetylazulenes [1a-13a]. Especially, 2,3-dimethyl-1-trichloroacetylazulene [5b] and 1,3-ditrichloroacetyl-4,6,8-trimethylazulene [11b] showed the highest cytotoxicity and tumor specificity (TS > 35.6 and > 44.1, respectively). These compounds induced internucleosomal DNA fragmentation in HL-60 cells, but not in HSC-2 and HSC-3 cells, but activated caspase-3, -8 and -9 in all of these cells, suggesting the activation of both mitochondria-independent (extrinsic) and dependent (intrinsic) pathways. Western blot analysis showed that two compounds [5b, 11b] slightly increased the intracellular concentration of pro-apoptotic proteins (Bad, Bax) in HSC-2 cells. None of the 26 compounds showed anti-HIV activity. These results suggest [5b] and [11b] as possible candidates for future cancer chemotherapy.


Subject(s)
Azulenes/pharmacology , Carcinoma, Squamous Cell/drug therapy , Mouth Neoplasms/drug therapy , Apoptosis/drug effects , Azulenes/chemistry , Carcinoma, Squamous Cell/pathology , Cell Line , Cell Line, Tumor , Drug Screening Assays, Antitumor , Fibroblasts/cytology , Fibroblasts/drug effects , HL-60 Cells , Humans , Hydrocarbons, Halogenated/chemistry , Hydrocarbons, Halogenated/pharmacology , Mouth Neoplasms/pathology , Structure-Activity Relationship
6.
Anticancer Res ; 25(6B): 4157-63, 2005.
Article in English | MEDLINE | ID: mdl-16309211

ABSTRACT

Azulenequinone derivatives have been reported to display a broad spectrum of biological activities, but study at the cellular level has been limited. The effect of twenty-seven azulenequinone derivatives on nitric oxide (NO) production by mouse macrophage-like cells Raw 264.7 was investigated in this study. All of these compounds failed to stimulate the Raw 264.7 cells to produce detectable amounts of NO, but did inhibit NO production by lipopolysaccharide (LPS)-activated Raw 264. 7 cells to varying extents. Compounds [7, 8, 9, 13, 16, 25, 27], which showed lesser cytotoxic activity (CC50 = 425, 381, 482, 179, 119, 235, 225 microM, respectively), inhibited NO production to the greatest extent [selectivity index (SI) = 15.4, 26.2, 3.9, 21.6, 3.1, 6.0, 8.4, respectively]. Western blot and RT-PCR analyses demonstrated that the most active derivatives, 3-morpholino-1, 5-azulenequinone [8] and 3,7-dibromo-1, 5-azulenequinone [13], significantly reduced both the intracellular concentration of iNOS protein and the expression of iNOS mRNA. ESR spectroscopy showed that compounds [8, 13] weakly scavenged NO produced by NOC-7, possibly via their general reducing activity. These data suggest that the inhibitory effect of NO production by compounds [8, 13] might be generated mostly via the inhibition of iNOS expression, rather than the radical-mediated mechanism.


Subject(s)
Azulenes/pharmacology , Lipopolysaccharides/antagonists & inhibitors , Macrophages/drug effects , Macrophages/metabolism , Nitric Oxide/antagonists & inhibitors , Nitric Oxide/biosynthesis , Quinones/pharmacology , Animals , Benzoates/metabolism , Benzoates/pharmacology , Blotting, Western , Cell Line , Cyclic N-Oxides/metabolism , Cyclic N-Oxides/pharmacology , Electron Spin Resonance Spectroscopy , Free Radical Scavengers/pharmacology , Hydrazines/metabolism , Hydrazines/pharmacology , Hypoxanthine/metabolism , Imidazoles/metabolism , Imidazoles/pharmacology , Lipopolysaccharides/pharmacology , Macrophages/enzymology , Mice , Nitric Oxide Donors/metabolism , Nitric Oxide Donors/pharmacology , Nitric Oxide Synthase Type II/biosynthesis , Nitric Oxide Synthase Type II/genetics , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction , Superoxides/metabolism , Xanthine Oxidase/metabolism
7.
Anticancer Res ; 25(1A): 305-12, 2005.
Article in English | MEDLINE | ID: mdl-15816552

ABSTRACT

We investigated twenty-seven azulenequinone derivatives for their relative cytotoxicity against three human normal cell lines (HGF, HPC, HPLF) and four human tumor cell lines (HSG, HSC-2, HSC-3, HL-60). Parent 1,5-azulenequinone showed potent and some tumor-specific cytotoxicity. Halogenated derivatives of 1,5- and 1,7-azulenequinone showed potent cytotoxicity, but lower tumor-specific cytotoxicity. In contrast to other azulenequinones, amino derivatives such as 3-amino-1,5- and 1, 7-azulenequinones showed relatively lower cytotoxic activity. The 3-Phenoxy-1,5-azuleneqinone derivative showed higher cytotoxicity than the 3-phenoxy-1, 7-azulenequinone derivative. 1,5- and 1,7-Azulenequinones generally showed higher cytotoxicity, as compared with tropolones and azulene derivatives. 3- (3-Guaiazulenyl)-1, 5-azulenequinone [12] and 7-isopropyl-3- (4-methylanilino)-2-methyl- 1, 5-azulenequinone [24] showed a relatively higher TS value and induced apoptosis (internucleosomal DNA fragmentation, activation of caspases 3, 8 and 9) in HL-60 and HSC-2 cells, possibly via the activation of both mitochondria-independent (extrinsic) and -dependent (intrinsic) pathways. Western blot analysis showed that [24] slightly increased the intracellular concentration of pro-apoptotic proteins (Bad, Bax) in HSC-2 cells, whereas [12] was much less active. None of the twenty-seven azulenequinones showed anti-HIV activity. These results suggest [12] and [24] as possible candidates for future cancer chemotherapy.


Subject(s)
Carcinoma, Squamous Cell/drug therapy , Cycloheptanes/pharmacology , Mouth Neoplasms/drug therapy , Quinones/pharmacology , Anti-HIV Agents/pharmacology , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Azulenes , Carcinoma, Squamous Cell/pathology , Cell Line, Tumor , Drug Screening Assays, Antitumor , HIV Infections/drug therapy , HIV-1 , HL-60 Cells , Humans , Mouth Neoplasms/pathology , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...